Jessie Myers
Family · Kokomo, INNPI 1942677943
Payments from drug & device makers
Across 268 payments — averaging $27.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Astellas Pharma US Inc$1K
- Teleflex LLC$676
- Boston Scientific$615
- Sumitomo Pharma America, Inc.$466
- Pfizer$416
- plus $3K from 39 others
What the payments were for
- Travel & lodging$1,76224%
- Food & beverage$4,77464%
- Education$95813%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$909
- UroLift$618
- ADSTILADRIN$117
How this compares
$7,493 in reported general payments places this provider in the 95th percentile of 4,392 family providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 162 | $150,318 |
| GemtesaVibegron | 126 | $127,427 |
| Mirabegron ErMirabegron | 56 | $56,282 |
| Tamsulosin Hcl | 803 | $15,493 |
| Oxybutynin Chloride ErOxybutynin Chloride | 185 | $5,511 |
| Potassium Citrate ErPotassium Citrate | 40 | $4,946 |
| Estradiol | 80 | $4,383 |
| Tolterodine Tartrate ErTolterodine Tartrate | 33 | $3,798 |
| Testosterone Cypionate | 84 | $3,304 |
| Solifenacin Succinate | 25 | $3,016 |
| Finasteride | 143 | $2,767 |
| Cephalexin | 227 | $1,568 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 101 | $1,421 |
| Dutasteride | 33 | $1,312 |
| NitrofurantoinNitrofurantoin Macrocrystal | 21 | $1,112 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $1,315 | $150,318162 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $466 | $127,427126 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,392 family providers in Indiana.
Other family in Kokomo
- Miranda TedderKokomo$15K
- Tina SizemoreIndianapolis$888K
- Kathalene Keller RineyEvansville$383K
- Robin AndersonPortage$333K
- Marla MosesIndianapolis$142K
- Justin BrownFort Wayne$142K
- Lacey MatheisEvansville$139K
- Myra SikwataHobart$131K
- Elizabeth JohnsonEvansville$108K
- Beverly MaugerFt Wayne$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.